Educational content on VJOncology is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.
Neal Shore, FACS, MD, Carolina Urologic Research Center, Myrtle Beach, SC, highlights a trial combining pembrolizumab with enfortumab vedotin versus pembrolizumab alone for patients with bladder cancer. This interview took place during the 2021 Genitourinary Cancers Symposium.